Clinical Trial Update: Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC) [NA]

View source ↗

Summary

A clinical trial evaluating Oligo-Fucoidan for advanced hepatocellular carcinoma has been terminated; no results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Oligo-Fucoidan

Snippet

Sponsor: Hi-Q Marine Biotech International, Ltd. | Conditions: Advanced Hepatocellular Carcinoma | NA | Status: TERMINATED